retatrutide obesity phase 2 trial just delivered the first top-line 3 results for a triple agonist in β and the findings from TRIUMPH-4 are strikingπ Great news again!!! A phase
Description
317E1081E1093

Mounjaro is a brand-name medication containing Tirzepatide, a new injectable treatment developed by Eli Lilly

& Zhang, Q
00092-0/asset/9cb4d176-26e3-4508-8aa1-ecdb4e971f8d/main.assets/gr3_lrg.jpg)
Contact your healthcare provider if heartburn persists beyond 1-2 weeks despite lifestyle changes and over-the-counter treatments, or if you experience red flag symptoms including difficulty swallowing, severe abdominal pain, persistent vomiting, or signs of gastrointestinal bleeding
Mortazavi uses Tirzepatide for both full-dose and microdose protocols based on clinical evidence showing superior outcomes and tolerability with its dual GLP-1/GIP mechanism

That means youre losing mostly fat and preserving muscle
